跳至主要内容
临床试验/NCT00719056
NCT00719056已完成4 期

Efficacy of Teicoplanin for the Prevention of Surgical Site Infections After Total Hip or Knee Arthroplasty: A Prospective, Open-Label Randomized Study

University of Athens3 个研究点 分布在 1 个国家目标入组 616 人开始时间: 2004年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
616
试验地点
3
主要终点
To compare the efficacy of single dose teicoplanin compared with comparator agents in the prevention of surgical site infections after total hip or knee arthroplasty.

研究概览

简要总结

This is a prospective, open-label, randomized clinical trial where patients were administered prophylaxis for total hip or knee arthroplasty either with teicoplanin or with other antibiotics. The study is aiming to evaluate any differences between these two different strategies of antimicrobial prophylaxis in the occurrence of surgical site infections

详细描述

This is a prospective, open-label, randomized clinical trial where patients were administered prophylaxis for total hip or knee arthroplasty either with a single dose of teicoplanin or with multiple doses of other antibiotics according to the habits of the attending physicians aiming to evaluate any differences between these two different strategies of antimicrobial prophylaxis in the occurrence of surgical site infections

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted for total hip arthroplasty
  • Patients admitted for total knee arthroplasty

排除标准

  • Revision arthroplasty
  • History of any infection within the preceding two months
  • History of an operation in the same hip or knee for other causes
  • Known history of allergy to the studied drug
  • Pregnancy or lactation
  • Any antibiotic therapy in the week before operation.

研究组 & 干预措施

1

Experimental

Surgical chemoprophylaxis of one dose of teicoplanin upon introduction of anesthesia for total hip or knee arthroplasty.

干预措施: Teicoplanin (Drug)

2

Active Comparator

Surgical chemoprophylaxis with multiple dose of other antimicrobials for up to six consecutive days for total hip or knee arthroplasty.

干预措施: β-lactams or ciprofloxacin (Drug)

结局指标

主要结局

To compare the efficacy of single dose teicoplanin compared with comparator agents in the prevention of surgical site infections after total hip or knee arthroplasty.

时间窗: Two years

次要结局

  • To compare the efficacy of single dose teicoplanin compared with comparator agents in the separate prevention of superficial or deep surgical site infections after total hip or knee arthroplasty.(Two years)

研究者

发起方
University of Athens
申办方类型
Other

研究点 (3)

Loading locations...

相似试验